Can a renewal be signed electronically?

Yes. Under the ESIGN Act and UETA, electronic signatures are legally valid if you demonstrate signer intent, consent to electronic transactions, attribution, and reliable record retention (15 U.S.C. ch. 96; UETA). Ensure the platform provides an audit trail and that any required disclosures are made for consumer-facing records.

Do I need a BAA for PHI in the form?

If the renewal includes protected health information and a third-party vendor will store or process PHI, execute a Business Associate Agreement (BAA) with the vendor to meet HIPAA obligations and record-retention and security requirements (45 CFR Part 160–164).

Who must sign the renewal?

The Principal Investigator typically signs attesting to accuracy; institutional sign-offs may include department chairs, research compliance officers, or delegates as specified by the IRB or sponsor.

What if I submitted incorrect information?

Contact the IRB immediately, submit an amendment or corrected renewal form per IRB instructions, and document corrective actions. Prompt disclosure reduces risk of noncompliance findings or study suspension.

Are notarization or witnesses required?

Not generally required for IRB renewals, but some institutions or state rules may demand notarization or witness signatures for specific attestations; confirm local policy or state law before assuming none are needed.

How long until the IRB responds?

Response time varies; standard administrative reviews may take 2–4 weeks, while expedited reviews are faster. Allow at least 30 days before current approval expires to avoid suspension.

Electronic Signature
Templates
Healthcare
Healthcare Study Renewal Form

Healthcare Study Renewal Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE STUDY RENEWAL FORM

Study Title: Protocol Number:

Principal Investigator: Study Site:

Participant Information

Full Legal Name

Date of Birth: Gender:

Address

Primary Phone: Email:

Emergency Contact

Name

Relationship: Phone:

Insurance Information

Insurance Provider

Policy Number: Group Number:

Subscriber Name (if different)

Renewal Request & Authorization

I request renewal of my participation in the study identified above. Select all that apply:

Continue participation under the current protocol and conditions.
Re-consent to the protocol as amended and described by the study team.
Extend authorization for use and disclosure of my health information for study-related analysis.
Renew HIPAA authorization for research and study follow-up.

Authorization Expiration Date

Updated Medical History

Current Medications Allergies (include drug and other) New Diagnoses or Chronic Conditions Since Last Visit Surgeries or Hospitalizations Since Last Visit

Have you experienced any serious adverse events, unexpected reactions, or hospital admissions related to study procedures since your last visit? Yes No

If yes, describe

HIPAA Authorization & Data Use

I authorize the study team and authorized representatives to use and disclose my protected health information (PHI) as described below for research, monitoring, regulatory compliance, and the purposes of this study. The PHI to be released may include medical history, laboratory results, imaging, and study-specific data collected during participation.

Purpose of disclosure: study conduct, data analysis, safety monitoring, publication (with identifiers removed, if applicable), and regulatory reporting. Recipients may include sponsor agents, regulatory authorities, and institutional review boards.

I understand that I may revoke this authorization at any time by submitting a signed written notice to the study site, except to the extent that action has already been taken in reliance on this authorization. Revocation will not affect uses and disclosures made prior to receipt of the revocation.

Scope of Authorization

Participant Acknowledgment

By signing below I certify that: I have had the opportunity to discuss this renewal with the study team; I understand the information provided about risks and potential benefits; I understand that participation is voluntary and that I may withdraw at any time without penalty or loss of benefits to which I am otherwise entitled; I authorize the continued collection and use of my PHI as indicated above.

I understand that information collected prior to revocation may still be used and disclosed as required for study oversight or regulatory obligations. I acknowledge receipt of any study amendment information provided with this renewal request.

Participant Printed Name:

Signature

Relationship to Participant (if signing on behalf of participant)

Date

What the Healthcare Study Renewal Form Is and when it applies

The Healthcare Study Renewal Form documents an investigator's request to continue human-subjects research or clinical study activities after the original approval period. It summarizes protocol amendments, enrollment updates, adverse events, and continuing review materials for the institutional review board (IRB), sponsor, or compliance office. The form establishes current contact details, confirms consent documents remain accurate, and certifies that monitoring and data-security measures continue to meet institutional and regulatory obligations. It is used to maintain ethical oversight and to demonstrate ongoing compliance with applicable laws and funder conditions.

Why a properly completed renewal form matters

A complete Healthcare Study Renewal Form preserves IRB approval, protects participant safety, and documents continued regulatory compliance. Accurate renewals reduce review delays, limit audit exposure, and help sponsors maintain funding and publication timelines.

Who typically completes and reviews renewals

Several roles prepare and act on Healthcare Study Renewal Forms; responsibilities vary by institution and study sponsor.

Principal Investigators and co-investigators who verify study status and sign attestations for continued conduct.
Research coordinators or study managers who gather supporting documents and complete administrative sections.
IRB administrators and compliance officers who review materials and issue continuing approval or stipulations.

Routing should ensure the PI certifies accuracy before submission; the IRB provides final authorization and documents the continuing review outcome in institutional records.

Step-by-step: filling the Healthcare Study Renewal Form

Follow a consistent sequence to reduce back-and-forth with the IRB and speed approval.

01

Prepare materials: Collect protocol changes, consent updates, safety reports, and enrollment counts.
02

Complete form: Enter updated answers, dates, and attach required supporting documents.
03

Sign and attest: PI signs certifying accuracy and compliance with human-subject protections.
04

Submit to IRB: Route through the institutional system or designated IRB submission portal.

How to configure an online renewal workflow

Set up a repeatable eWorkflow that collects signatures, attachments, and routing approvals.

Field	Configuration
Routing order	PI → Compliance → IRB Administrator
Required attachments	Consent forms, protocol amendments, safety reports
Authentication	Email + optional SMS or institutional SSO
Retention setting	Store signed PDF with audit trail for required retention period

Digital signing and eSubmission essentials

Use a platform that supports secure uploads, audit trails, and HIPAA-compliant workflows when protected health information is present.

File formats: PDF, DOCX accepted
Authentication: Email link, SMS code, or SSO
Audit data: IP address, timestamps, and signer identity

Ensure the chosen eSignature provider will sign a Business Associate Agreement (BAA) if PHI is stored or transmitted, uses TLS 1.2/1.3 in transit and AES-256 at rest, and provides an immutable audit trail to meet institutional and HIPAA requirements.

Where to send the completed renewal form

Submission targets depend on whether the study is locally managed, IRB of record, or sponsor-monitored.

Local IRB: Upload to the institution's IRB portal or email designated IRB inbox.
Central IRB: Submit via central IRB's electronic system and notify local site contacts.
Sponsor: Provide sponsor-required documents through sponsor portal or designated contact.
ClinicalTrials.gov: Update study status and submission dates where registration requires it.

Core sections of a professional renewal form

A complete form groups administrative data, protocol changes, participant safety, consent status, continuing review items, and signatures.

Administrative details

Study title, IRB protocol number, sponsor, site location, and PI contact information to ensure accurate record matching and communication.

Protocol amendments

Clear description of substantive changes, rationale, and attached redlines or updated protocol documents for reviewer assessment.

Enrollment and demographics

Current enrollment totals, inclusion/exclusion updates, and demographic summaries that allow assessment of participant risk and representativeness.

Safety reporting

Summary of adverse events, unanticipated problems, and safety monitoring activities with links to detailed reports and DSMB notes.

Consent documentation

Status of informed consent forms, any reconsent requirements, and copies of revised consent for review and approval.

Certifications and signatures

PI attestation, institutional sign-offs, and signature blocks with dates; document whether eSign or wet signatures were used.

Required data fields at a glance

Participant ID: Study-assigned ID

Study Title: Full official title

Renewal Period: Start and end dates

Principal Investigator: Name and affiliation

IRB Number: Assigned protocol ID

Signatures: PI and authorized reviewers

Common timelines and processing expectations

Plan submissions so IRB review and any required sponsor approvals complete before institutional expiration dates.

Submission lead time:

At least 30 days before approval expiration

IRB review window:

Standard review takes about 2–4 weeks

Sponsor review:

Allow additional 1–3 weeks if sponsor approval required

Continuing review frequency:

Typically annual unless IRB sets a different interval

Late submission consequences:

Study suspension until approval is reinstated

Frequent errors that delay renewals

Missing or mismatched IRB protocol numbers cause administrative rejection and re-routing delays.
Incomplete adverse event summaries necessitate follow-up and extend the review timeline by days or weeks.
Attestation or signature fields left unsigned force resubmission and pause the continuing review process.
Failure to attach revised consent forms or redlines prevents evaluators from assessing participant information adequacy.

Risks and regulatory consequences of incorrect renewals

Loss of IRB approval: Study suspension

Funding impact: Sponsor suspension or delayed payments

HIPAA violations: Possible fines (45 CFR §160)

Research misconduct: Investigation and reputational harm

Regulatory citations: FDA or OHRP follow-up

Data integrity risk: Loss of usable data or exclusion from analyses

Typical eSignature vendor comparison for study renewals

Compare core pricing and feature differences when choosing an eSignature provider for Healthcare Study Renewal Forms; signNow is listed first per vendor-comparison conventions.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by vendor	Varies by vendor	Varies by vendor	Varies by vendor
Bulk Send	Yes (Business Premium)	Yes	Yes	Yes	Varies
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes (BAA available)	Yes (BAA available)	Yes (BAA available)	No	No
Envelope Cap	No envelope cap	100 envelopes/user/year limit	Varies	Varies	Varies

Frequently asked questions about renewals and e-signatures

Answers below address common procedural and compliance questions that arise during Healthcare Study Renewal Form completion.

Need help? Contact support

Can a renewal be signed electronically?
Yes. Under the ESIGN Act and UETA, electronic signatures are legally valid if you demonstrate signer intent, consent to electronic transactions, attribution, and reliable record retention (15 U.S.C. ch. 96; UETA). Ensure the platform provides an audit trail and that any required disclosures are made for consumer-facing records.
Do I need a BAA for PHI in the form?
If the renewal includes protected health information and a third-party vendor will store or process PHI, execute a Business Associate Agreement (BAA) with the vendor to meet HIPAA obligations and record-retention and security requirements (45 CFR Part 160–164).
Who must sign the renewal?
The Principal Investigator typically signs attesting to accuracy; institutional sign-offs may include department chairs, research compliance officers, or delegates as specified by the IRB or sponsor.
What if I submitted incorrect information?
Contact the IRB immediately, submit an amendment or corrected renewal form per IRB instructions, and document corrective actions. Prompt disclosure reduces risk of noncompliance findings or study suspension.
Are notarization or witnesses required?
Not generally required for IRB renewals, but some institutions or state rules may demand notarization or witness signatures for specific attestations; confirm local policy or state law before assuming none are needed.
How long until the IRB responds?
Response time varies; standard administrative reviews may take 2–4 weeks, while expedited reviews are faster. Allow at least 30 days before current approval expires to avoid suspension.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now